Bdparp 150 Tablet Substitute
Intas Pharmaceuticals Ltd
₹5812.5
(₹193.75 per unit)
Adley Formulations
₹12938
(₹215.63 per unit)
Dr Reddy's Laboratories Ltd
₹13125
(₹218.75 per unit)
Natco Pharma Ltd
₹7453
(₹248.43 per unit)
Cipla Ltd
₹2008
(₹251.0 per unit)
Zydus Healthcare Ltd
₹15449
(₹257.48 per unit)
Medion Biotech Pvt Ltd
₹16000
(₹266.67 per unit)
Eris Life Sciences Ltd
₹18843.5
(₹314.06 per unit)
Lupin Ltd
₹22875
(₹381.25 per unit)
Sun Pharmaceutical Industries Ltd
₹23906
(₹398.43 per unit)
Medicamen Biotech Ltd
₹12600
(₹420.0 per unit)
Samarth Life Sciences Pvt Ltd
₹21093.5
(₹703.12 per unit)
Emcure Pharmaceuticals Ltd
₹45000
(₹750.0 per unit)
Maximal Healthcare Pvt Ltd
₹54000
(₹900.0 per unit)
Astra Zeneca Pharma India Ltd
₹41025.5
(₹5128.19 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Bdparp 150 Tablet to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - OLAPARIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Bdparp 150 Tablet is used in the treatment of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Bdparp 150 Tablet are as follows:
Bdparp 150 Tablet helps manage certain advanced cancers by targeting specific cancer cells and interfering with their ability to repair themselves.
The following are the benefits of this medication:
RX
RX